Ameri100 Announces Conference Call to Discuss Merger With Jay Pharma

ATLANTA, Jan. 13, 2020 (GLOBE NEWSWIRE) -- AMERI Holdings, Inc. (NASDAQ: AMRH) (a??Ameria??), will host a conference call and webcast at 4:15 p.m. ET on Thursday, January 16, 2020, to discuss its entry into an amalgamation agreement (the a??transactiona??) announced today whereby the shareholders of Jay Pharma will become the majority holders of Ameria??s outstanding stock.
Jay Pharma is an evidence-based cannabinoid & wellness company focused on cancer. The company holds an exclusive license with Tikun Olam for cannabinoid intellectual property, including data and genetics for cancer patient care. Jay Pharmaa??s world class management & oncology teams are developing safe, clinically validated cannabinoid products.A A Joining Barry Kostiner, CFO of Ameri, to discuss the merger and the market opportunity for Jay Pharma will be Dave Johnson, who will be appointed Chairman and CEO of Jay Pharma upon closing of the transaction.CONFERENCE CALL & WEBCAST INFORMATION:


Thursday, January 16, 2020, at 4:15 p.m. ET


Via phone by dialing +1 833-366-1126 or +1 412-902-6772 and asking for the Ameri call; via live and archived webcast: A

A telephonic replay of the conference call may be accessed until the closing of the transaction by dialing +1 877-344-7529 or +1 412-317-0088 with passcode 10138473.A  A 
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«    Январь 2020    »